News - Page 94 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article MindMed Announces First Patient Dosed in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder

MindMed Announces First Patient Dosed in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder

Post published:August 25, 2022
Post category:Press Release

Read more about the article FILAMENT HEALTH APPOINTS NEW MEMBERS TO BOARD OF DIRECTORS AND ADVISORY COUNCIL

FILAMENT HEALTH APPOINTS NEW MEMBERS TO BOARD OF DIRECTORS AND ADVISORY COUNCIL

Post published:August 25, 2022
Post category:Press Release

Read more about the article BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity with Possible Nootropic Effects Similar to That of LSD Without Hallucinogenic Side Effects

BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity with Possible Nootropic Effects Similar to That of LSD Without Hallucinogenic Side Effects

Post published:August 25, 2022
Post category:Press Release

Read more about the article Clearmind Medicine Announces Additional Positive Pre-Clinical Results for its Cocaine Addiction Treatment

Clearmind Medicine Announces Additional Positive Pre-Clinical Results for its Cocaine Addiction Treatment

Post published:August 24, 2022
Post category:Press Release

Read more about the article Algernon Pharmaceuticals’ Largest Shareholder AlphaNorth Asset Management Increases Ownership Position

Algernon Pharmaceuticals’ Largest Shareholder AlphaNorth Asset Management Increases Ownership Position

Post published:August 24, 2022
Post category:Press Release

Read more about the article GH Research Reports Second Quarter 2022 Financial Results and Provides Business Updates

GH Research Reports Second Quarter 2022 Financial Results and Provides Business Updates

Post published:August 23, 2022
Post category:Press Release

Read more about the article Opinions | The Psychedelic Community Takes Itself Too Seriously

Opinions | The Psychedelic Community Takes Itself Too Seriously

Post published:August 22, 2022
Post category:Opinions

Read more about the article Algernon Pharmaceuticals Announces Private Placement

Algernon Pharmaceuticals Announces Private Placement

Post published:August 20, 2022
Post category:Press Release

Read more about the article Psychedelic Bulletin #115 – Mydecine Looks Set to Shutter; MindMed Gains ‘Meme Stock’ Status; atai ‘Streamlilnes’ Pipeline; California Decrim. Bill Gutted

Psychedelic Bulletin #115 – Mydecine Looks Set to Shutter; MindMed Gains ‘Meme Stock’ Status; atai ‘Streamlilnes’ Pipeline; California Decrim. Bill Gutted

Post published:August 19, 2022
Post category:Psychedelic Bulletin

Read more about the article Interview | Josh Ismin, Psylo

Interview | Josh Ismin, Psylo

Post published:August 19, 2022
Post category:Interview

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.